Phospho-PKC gamma (Thr655) Antibody - #AF8398
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF8398, RRID:AB_2840459.
展开/折叠
KPCG_HUMAN; MGC57564; OTTHUMP00000067291; PKC-gamma; PKCC; PKCG; PRKCG; Protein kinase C gamma; Protein kinase C gamma polypeptide; Protein kinase C gamma type; Protein kinase C, gamma; SCA 14; SCA14;
抗原和靶标
- P05129 KPCG_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAGLGPGVGDSEGGPRPLFCRKGALRQKVVHEVKSHKFTARFFKQPTFCSHCTDFIWGIGKQGLQCQVCSFVVHRRCHEFVTFECPGAGKGPQTDDPRNKHKFRLHSYSSPTFCDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGVDHTERRGRLQLEIRAPTADEIHVTVGEARNLIPMDPNGLSDPYVKLKLIPDPRNLTKQKTRTVKATLNPVWNETFVFNLKPGDVERRLSVEVWDWDRTSRNDFMGAMSFGVSELLKAPVDGWYKLLNQEEGEYYNVPVADADNCSLLQKFEACNYPLELYERVRMGPSSSPIPSPSPSPTDPKRCFFGASPGRLHISDFSFLMVLGKGSFGKVMLAERRGSDELYAIKILKKDVIVQDDDVDCTLVEKRVLALGGRGPGGRPHFLTQLHSTFQTPDRLYFVMEYVTGGDLMYHIQQLGKFKEPHAAFYAAEIAIGLFFLHNQGIIYRDLKLDNVMLDAEGHIKITDFGMCKENVFPGTTTRTFCGTPDYIAPEIIAYQPYGKSVDWWSFGVLLYEMLAGQPPFDGEDEEELFQAIMEQTVTYPKSLSREAVAICKGFLTKHPGKRLGSGPDGEPTIRAHGFFRWIDWERLERLEIPPPFRPRPCGRSGENFDKFFTRAAPALTPPDRLVLASIDQADFQGFTYVNPDFVHPDARSPTSPVPVPVM
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - P05129 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S109 | Phosphorylation | Uniprot | |
S145 | Phosphorylation | Uniprot | |
S148 | Phosphorylation | Uniprot | |
T155 | Phosphorylation | Uniprot | |
Y195 | Phosphorylation | Uniprot | |
K197 | Acetylation | Uniprot | |
K197 | Ubiquitination | Uniprot | |
S264 | Phosphorylation | Uniprot | |
S320 | Phosphorylation | Uniprot | |
S342 | Phosphorylation | Uniprot | |
K359 | Acetylation | Uniprot | |
K359 | Ubiquitination | Uniprot | |
S361 | Phosphorylation | Uniprot | |
K503 | Acetylation | Uniprot | |
T510 | Phosphorylation | Uniprot | |
T511 | Phosphorylation | Uniprot | |
T512 | Phosphorylation | Uniprot | |
T514 | Phosphorylation | Uniprot | |
T518 | Phosphorylation | Uniprot | |
Y521 | Phosphorylation | Uniprot | |
Y529 | Phosphorylation | Uniprot | |
T655 | Phosphorylation | Uniprot | |
T674 | Phosphorylation | Uniprot |
翻译修饰 - P05129 作为激酶
Substrate | Site | Source |
---|---|---|
O94768 (STK17B) | S351 | Uniprot |
P04004 (VTN) | S381 | Uniprot |
P04049 (RAF1) | S497 | Uniprot |
P04049 (RAF1) | S619 | Uniprot |
P04083 (ANXA1) | S27 | Uniprot |
P06127 (CD5) | T434 | Uniprot |
P06127 (CD5) | T436 | Uniprot |
P06730-1 (EIF4E) | S209 | Uniprot |
P07900 (HSP90AA1) | T115 | Uniprot |
P07900 (HSP90AA1) | T425 | Uniprot |
P07900 (HSP90AA1) | T603 | Uniprot |
P08138 (NGFR) | S277 | Uniprot |
P10636-8 (MAPT) | S258 | Uniprot |
P10636-8 (MAPT) | S293 | Uniprot |
P10636-8 (MAPT) | S324 | Uniprot |
P10636-8 (MAPT) | S352 | Uniprot |
P11388-1 (TOP2A) | S29 | Uniprot |
P17302 (GJA1) | S368 | Uniprot |
P19429 (TNNI3) | S42 | Uniprot |
P19429 (TNNI3) | S44 | Uniprot |
P21730 (C5AR1) | S334 | Uniprot |
P25098 (GRK2) | S29 | Uniprot |
P28329-3 (CHAT) | T255 | Uniprot |
P28329-3 (CHAT) | S346 | Uniprot |
P28329-3 (CHAT) | S347 | Uniprot |
P28329 (CHAT) | T373 | Uniprot |
P28329-3 (CHAT) | S440 | Uniprot |
P28329 (CHAT) | S464 | Uniprot |
P28329 (CHAT) | S465 | Uniprot |
P28329-3 (CHAT) | S476 | Uniprot |
P28329 (CHAT) | S558 | Uniprot |
P28329 (CHAT) | S594 | Uniprot |
P29474 (NOS3) | T495 | Uniprot |
P30086 (PEBP1) | S153 | Uniprot |
P34741 (SDC2) | S187 | Uniprot |
P34741 (SDC2) | S188 | Uniprot |
P35568 (IRS1) | S1101 | Uniprot |
P41180 (CASR) | T888 | Uniprot |
P41594-2 (GRM5) | S840 | Uniprot |
P43629 (KIR3DL1) | S415 | Uniprot |
P48058 (GRIA4) | S862 | Uniprot |
P49619 (DGKG) | S779 | Uniprot |
P49619 (DGKG) | S782 | Uniprot |
P49768 (PSEN1) | S346 | Uniprot |
P49840 (GSK3A) | S21 | Uniprot |
P49841 (GSK3B) | S9 | Uniprot |
P50281 (MMP14) | T567 | Uniprot |
P61764-2 (STXBP1) | S306 | Uniprot |
P61764-1 (STXBP1) | S313 | Uniprot |
P98082 (DAB2) | S24 | Uniprot |
Q03721 (KCNC4) | S8 | Uniprot |
Q03721 (KCNC4) | S9 | Uniprot |
Q03721 (KCNC4) | S15 | Uniprot |
Q03721 (KCNC4) | S21 | Uniprot |
Q05586 (GRIN1) | S890 | Uniprot |
Q13224 (GRIN2B) | S1303 | Uniprot |
Q13224 (GRIN2B) | S1323 | Uniprot |
Q14155 (ARHGEF7) | S518 | Uniprot |
Q14155 (ARHGEF7) | S761 | Uniprot |
Q16625-1 (OCLN) | S340 | Uniprot |
Q5JVS0-1 (HABP4) | T354 | Uniprot |
Q5JVS0 (HABP4) | T375 | Uniprot |
Q7Z2E3 (APTX) | T125 | Uniprot |
Q92686 (NRGN) | S36 | Uniprot |
Q99418-2 (CYTH2) | S391 | Uniprot |
Q99418-1 (CYTH2) | S392 | Uniprot |
Q9UBS0 (RPS6KB2) | S473 | Uniprot |
Q9UQ80-1 (PA2G4) | S363 | Uniprot |
Q9UQ80-1 (PA2G4) | T366 | Uniprot |
研究背景
Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress. Binds and phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its function by increasing plasma membrane-associated GRIA4 expression. In primary cerebellar neurons treated with the agonist 3,5-dihyidroxyphenylglycine, functions downstream of the metabotropic glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor which plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. May be involved in the regulation of hippocampal long-term potentiation (LTP), but may be not necessary for the process of synaptic plasticity. May be involved in desensitization of mu-type opioid receptor-mediated G-protein activation in the spinal cord, and may be critical for the development and/or maintenance of morphine-induced reinforcing effects in the limbic forebrain. May modulate the functionality of mu-type-opioid receptors by participating in a signaling pathway which leads to the phosphorylation and degradation of opioid receptors. May also contributes to chronic morphine-induced changes in nociceptive processing. Plays a role in neuropathic pain mechanisms and contributes to the maintenance of the allodynia pain produced by peripheral inflammation. Plays an important role in initial sensitivity and tolerance to ethanol, by mediating the behavioral effects of ethanol as well as the effects of this drug on the GABA(A) receptors. During and after cerebral ischemia modulate neurotransmission and cell survival in synaptic membranes, and is involved in insulin-induced inhibition of necrosis, an important mechanism for minimizing ischemic injury. Required for the elimination of multiple climbing fibers during innervation of Purkinje cells in developing cerebellum. Is activated in lens epithelial cells upon hydrogen peroxide treatment, and phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of GJA1 gap junction plaques and inhibition of gap junction activity which could provide a protective effect against oxidative stress (By similarity). Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in response to DNA damage. Involved in the phase resetting of the cerebral cortex circadian clock during temporally restricted feeding. Stabilizes the core clock component ARNTL/BMAL1 by interfering with its ubiquitination, thus suppressing its degradation, resulting in phase resetting of the cerebral cortex clock (By similarity).
Autophosphorylation on Thr-674 appears to regulate motor functions of junctophilins, JPH3 and JPH4.
Ubiquitinated.
Cytoplasm. Cytoplasm>Perinuclear region. Cell membrane>Peripheral membrane protein. Cell junction>Synapse>Synaptosome. Cell projection>Dendrite.
Note: Translocates to synaptic membranes on stimulation.
Expressed in Purkinje cells of the cerebellar cortex.
Interacts with GRIA4 (By similarity). Interacts with CDCP1. Interacts with TP53INP1 and p53/TP53. Interacts with ARNTL/BMAL1 (By similarity).
Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.
研究领域
· Cellular Processes > Cellular community - eukaryotes > Focal adhesion. (View pathway)
· Cellular Processes > Cellular community - eukaryotes > Gap junction. (View pathway)
· Environmental Information Processing > Signal transduction > MAPK signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > ErbB signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Ras signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Rap1 signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Calcium signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > HIF-1 signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Phosphatidylinositol signaling system.
· Environmental Information Processing > Signal transduction > Sphingolipid signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > mTOR signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Wnt signaling pathway. (View pathway)
· Human Diseases > Drug resistance: Antineoplastic > EGFR tyrosine kinase inhibitor resistance.
· Human Diseases > Substance dependence > Amphetamine addiction.
· Human Diseases > Substance dependence > Morphine addiction.
· Human Diseases > Infectious diseases: Parasitic > African trypanosomiasis.
· Human Diseases > Infectious diseases: Parasitic > Amoebiasis.
· Human Diseases > Infectious diseases: Viral > Hepatitis B.
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cancers: Overview > Proteoglycans in cancer.
· Human Diseases > Cancers: Overview > MicroRNAs in cancer.
· Human Diseases > Cancers: Specific types > Glioma. (View pathway)
· Human Diseases > Cancers: Specific types > Non-small cell lung cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Hepatocellular carcinoma. (View pathway)
· Human Diseases > Cancers: Overview > Choline metabolism in cancer. (View pathway)
· Organismal Systems > Circulatory system > Vascular smooth muscle contraction. (View pathway)
· Organismal Systems > Immune system > Natural killer cell mediated cytotoxicity. (View pathway)
· Organismal Systems > Immune system > Fc gamma R-mediated phagocytosis. (View pathway)
· Organismal Systems > Immune system > Leukocyte transendothelial migration. (View pathway)
· Organismal Systems > Environmental adaptation > Circadian entrainment.
· Organismal Systems > Nervous system > Long-term potentiation.
· Organismal Systems > Nervous system > Retrograde endocannabinoid signaling. (View pathway)
· Organismal Systems > Nervous system > Glutamatergic synapse.
· Organismal Systems > Nervous system > Cholinergic synapse.
· Organismal Systems > Nervous system > Serotonergic synapse.
· Organismal Systems > Nervous system > GABAergic synapse.
· Organismal Systems > Nervous system > Dopaminergic synapse.
· Organismal Systems > Nervous system > Long-term depression.
· Organismal Systems > Sensory system > Inflammatory mediator regulation of TRP channels. (View pathway)
· Organismal Systems > Endocrine system > Insulin secretion. (View pathway)
· Organismal Systems > Endocrine system > Melanogenesis.
· Organismal Systems > Endocrine system > Thyroid hormone synthesis.
· Organismal Systems > Endocrine system > Thyroid hormone signaling pathway. (View pathway)
· Organismal Systems > Endocrine system > Oxytocin signaling pathway.
· Organismal Systems > Endocrine system > Aldosterone synthesis and secretion.
· Organismal Systems > Excretory system > Aldosterone-regulated sodium reabsorption.
· Organismal Systems > Excretory system > Endocrine and other factor-regulated calcium reabsorption.
· Organismal Systems > Digestive system > Salivary secretion.
· Organismal Systems > Digestive system > Gastric acid secretion.
· Organismal Systems > Digestive system > Pancreatic secretion.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.